Gastroenterology
Volume 138, Issue 2 , Pages 682-693.e4 , February 2010

Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B

  • Paola Fisicaro

      Affiliations

    • Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • ,
  • Caterina Valdatta

      Affiliations

    • Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • ,
  • Marco Massari

      Affiliations

    • Unit of Infectious Diseases, Azienda Ospedaliera S.M.N. di Reggio Emilia; Reggio Emilia, Italy
    • ,
  • Elisabetta Loggi

      Affiliations

    • Department of Clinical Medicine, Laboratory of Cellular Immunology, University of Bologna, Bologna, Italy
    • ,
  • Elisabetta Biasini

      Affiliations

    • Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • ,
  • Luca Sacchelli

      Affiliations

    • Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • ,
  • Maria Cristina Cavallo

      Affiliations

    • Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • ,
  • Enrico M. Silini

      Affiliations

    • Anatomia e Istologia Patologica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • ,
  • Pietro Andreone

      Affiliations

    • Department of Clinical Medicine, Laboratory of Cellular Immunology, University of Bologna, Bologna, Italy
    • ,
  • Gabriele Missale

      Affiliations

    • Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • ,
  • Carlo Ferrari

      Affiliations

    • Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
    • Corresponding Author InformationReprint requests Address requests for reprints to: Carlo Ferrari, MD, Professor, Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci, 14, 43100 Parma, Italy. fax: (39) 0521-703 857

Received 6 March 2009 ,Accepted 17 September 2009.

References 

  1. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003;38:4–13
  2. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215–229
  3. Das A, Hoare M, Davies N, et al. Functional skewing of the global CD8 T-cell population in chronic hepatitis B virus infection. J Exp Med. 2008;205:2111–2124
  4. Chang JJ, Thompson AJV, Visvanathan K, et al. The phenotype of hepatitis B virus-specific T cells differs in the liver and blood in chronic hepatitis B virus infection. Hepatology. 2007;46:1332–1340
  5. Zhang Z, Zhang J-Y, Wherry EJ, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology. 2008;134:1938–1949
  6. Boni C, Fisicaro P, Valdatta C, et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 2007;81:4215–4225
  7. Lopes AR, Kellam P, Das A, et al. Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection. J Clin Invest. 2008;118:1835–1845
  8. Barber DL, Wherry EJ, Masopust B, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439:682–687
  9. Maier H, Isogawa M, Freeman GJ, et al. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol. 2007;178:2714–2720
  10. Velu V, Titanji K, Zhu B, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 2009;458:206–210
  11. Finnefrock AC, Tang A, Fengsheng L, et al. PD-1 blockade in rhesus macaques: impact on chronic infection and prophilactic vaccination. J Immunol. 2009;182:980–987
  12. Ha SJ, Mueller SN, Wherry EJ, et al. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med. 2008;205:543–555
  13. Freeman GJ, Wherry EJ, Ahmed R, et al. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med. 2006;203:2223–2227
  14. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350–354
  15. Trautmann L, Janbazian L, Chomont N, et al. Up-regulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med. 2006;12:1198–1202
  16. Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med. 2006;203:2281–2292
  17. Urbani S, Amadei B, Tola D, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol. 2006;80:11398–11403
  18. Radziewicz H, Ibegbu CC, Fernandez ML, et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol. 2006;81:2545–2553
  19. Golden-Mason L, Palmer B, Klarquist J, et al. Up-regulation of PD-1 expression on circulating and intrahepatic HCV-specific CD8+T cells associated with reversible immune dysfunction. J Virol. 2007;81:9249–9258
  20. Penna A, Pilli M, Zerbini A, et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology. 2007;45:588–601
  21. Nakamoto N, Kaplan DE, Coleclough J, et al. Functional restoration of HCV-specific CD8 T cells by PD1 blockade is defined by PD1 expression and compartmentalization. Gastroenterology. 2008;134:1927–1937
  22. Van Leeuwen EMM, de Bree GJ, Remmerswaal EBM, et al. IL-7 receptor α chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood. 2005;106:2091–2098
  23. Kaech SM, Tan JT, Wherry EJ, et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4:1191–1198
  24. Wherry EJ, Barber DL, Kaech SM, et al. Antigen-independent memory CD8 T cell do not develop during chronic viral infection. Proc Natl Acad Sci U S A. 2004;101:16004–16009
  25. Bengsch B, Spangenberg N, Kersting C, et al. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol. 2007;81:945–953
  26. Heydtmann M, Hardie D, Shields PL, et al. Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes. J Immunol. 2006;177:729–738
  27. Muhlbauer M, Fleck M, Schutz C, et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T-cell apoptosis. J Hepatol. 2006;45:520–528
  28. Chain BM, Myers R. Variability and conservation in hepatitis B virus core protein. BMC Microbiol. 2005;5:33–46
  29. Wherry EJ, Blattman JN, Murali-Krishna K, et al. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77:4911–4927
  30. Wherry EJ, Ha SJ, Kaech SM, et al. Molecular signature of CD8+ T-cell exhaustion during chronic viral infection. Immunity. 2007;27:670–684
  31. Webster GJM, Reignat S, Brown D, et al. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol. 2004;78:5707–5719
  32. Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med. 2000;191:1269–1280
  33. Franceschini D, Paroli M, Francavilla V, et al. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest. 2009;119:551–564
  34. Blackburn SD, Shin H, Haining WN, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009;10:29–37
  35. Kaufmann DE, Kavanagh DG, Pereyra F, et al. Up-regulation of CTLA-4 by HIV-specific CD4+ T cells correlates with diseases progression and defines a reversible immune dysfunction. Nat Immunol. 2007;8:1246–1254
  36. Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T-cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 2009;[Epub ahead of print]
  37. Berger R, Rotem-Yehudar R, Slama G, et al. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res. 2008;14:3044–3051

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the VIRGIL EC grant QLK2-CT-2002-00700; by Fondazione Cassa Risparmio di Parma, Parma, Italy; by grant 85/2007, Ricerca Finalizzata, Progetto Ordinario, Ministry of Health, Italy; and by Fondo per gli Investimenti della Ricerca di Base (grant No. RBNE013PMJ); and by the Ministry of Instruction, University and Research, Italy.

PII: S0016-5085(09)01747-8

doi: 10.1053/j.gastro.2009.09.052

Gastroenterology
Volume 138, Issue 2 , Pages 682-693.e4 , February 2010

Article Tools

* Image Usage & Resolution